Types of Interventions Made by Clinical Pharmacists in the IMPROVE Study
- 1 April 2000
- journal article
- clinical trial
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 20 (4) , 429-435
- https://doi.org/10.1592/phco.20.5.429.35055
Abstract
The purpose of this study was to describe and evaluate the activities and interventions provided by ambulatory care clinical pharmacists during the IMPROVE (Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers) study. A total of 523 patients were randomized into the intervention arm at nine Veterans Affairs medical centers if they were considered to be at high risk for drug-related problems. Patients randomized to the control group had no interventions and they are not reported. Using a standard form, pharmacists were asked to document the length of visit, method of contact, medical conditions addressed, and drug-related problems addressed and resolved during each contact. Seventy-eight ambulatory care clinical pharmacists documented 1855 contacts over 12 months, an average of 3.54 +/- 2.31/patient. The length of visits was 15 minutes or more for 73% of contacts. In-person contacts accounted for 1421 visits (76.6%), with the remainder being telephone contacts. During each contact the average number of drug-related problems addressed and resolved were 1.64 +/- 1.16 and 1.14 +/- 0.98, respectively. More drug-related problems were addressed and resolved when visits were 15 minutes or longer (p=0.001) and when the contact was in person (p=0.001). These data may provide information to clinical pharmacists developing pharmacy-managed clinics for patients at high risk for drug-related problems. The information may be a benchmark for types of interventions that can be made, as well as the time commitments required to make them.Keywords
This publication has 15 references indexed in Scilit:
- Assessing the structure and process for providing pharmaceutical care in Veterans Affairs medical centers.American Journal of Health-System Pharmacy, 2000
- Reduction in Heart Failure Events by the Addition of a Clinical Pharmacist to the Heart Failure Management TeamArchives of internal medicine (1960), 1999
- Part 2. Clinical and Economic Outcomes in the Hypertension and COPD Arms of a Multicenter Outcomes StudyJournal of the American Pharmaceutical Association, 1998
- Comparison of an Anticoagulation Clinic With Usual Medical CareArchives of internal medicine (1960), 1998
- Management of Patients with Type 2 Diabetes by Pharmacists in Primary Care ClinicsAnnals of Pharmacotherapy, 1998
- Comprehensive Pharmaceutical Care in the Chain SettingJournal of the American Pharmaceutical Association, 1996
- A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacyThe American Journal of Medicine, 1996
- A General Method of Compliance Assessment Using Centralized Pharmacy RecordsMedical Care, 1988
- Cost-Justification of a Clinical Pharmacist-Managed Anticoagulation ClinicDrug Intelligence & Clinical Pharmacy, 1985
- Sustained Improvement in Drug Documentation, Compliance, and Disease ControlArchives of internal medicine (1960), 1984